138309-84-9

Upstream product

• 143571-97-5 4,6-O-benzylidene-N-benzyloxycarbonyl-3-O-chloroacetyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 130539-12-7 N-Benzyloxycarbonyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 19130-96-2 1,5-dideoxy-1,5-imino-D-glucitol 
• 100-52-7 benzaldehyde 
• 501-53-1 benzyl chloroformate 
• 134336-18-8 4,6-O-Benzylidene-N-benzyloxycarbonyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 75-36-5 acetyl chloride 

Downstream Products

• 143599-89-7 (4aR,7S,8R,8aR)-7-Acetoxy-2-phenyl-8-((2S,3S,4R,5R,6S)-3,4,5-tris-benzyloxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexahydro-[1,3]dioxino[5,4-b]pyridine-5-carboxylic acid benzyl ester 
• 143571-98-6 (2R,3R,4S,5S)-5-Acetoxy-2-benzyloxymethyl-3-hydroxy-4-((2S,3S,4R,5R,6S)-3,4,5-tris-benzyloxy-6-methyl-tetrahydro-pyran-2-yloxy)-piperidine-1-carboxylic acid benzyl ester 

Relevant academic research and scientific papers

Lewis-type sugar chain derivative

The object of the present invention is to provide a new SLe-type sugar chain derivative represented by the following formula (I), which is useful as a pharmaceutical and which contains moranoline: STR1 wherein R1 represents hydrogen, a lower al

Synthesis of 1-deoxynojirimycin-containing glycans related to the Lewis X and sialyl-Lewis X epitopes recognized by LEC-CAMs

This paper decribes the synthesis of 1-deoxynojirimycin-containing glycans related to the Lewis X and sialyl-Lewis X epitopes recognized by LEC-CAMs.

Selective functionalization of the C2 hydroxyl group of N-carbobenzyloxy-4,6-O-benzylidene-1-deoxynojirimycin

1-Deoxynojirimycin was converted into its N-CBZ-4,6-O-benzylidene derivative 2 in two steps in 51% yield. Compound 2 could be regioselectively functionalized at the C2 hydroxyl group by activation with di-n-butyltin oxide, followed by reaction of the resu